A Multicentered, Randomized, Controlled Trial Comparing Radioguided Seed Localization to Standard Wire Localization for Nonpalpable, Invasive and in situ Breast Carcinomas
暂无分享,去创建一个
C. Goldsmith | D. McCready | C. Boylan | M. Reedijk | P. Lovrics | S. Cornacchi | N. Hodgson | G. Gohla
[1] Y. Khaliq,et al. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans , 2012 .
[2] G. Nieuwenhuijzen,et al. Localization of non‐palpable breast cancer using a radiolabelled titanium seed , 2010, The British journal of surgery.
[3] M. Ulissey,et al. Experience with Seed Localization for Nonpalpable Breast Lesions in a Public Health Care System , 2010, Annals of Surgical Oncology.
[4] Richard J Gray,et al. Current status of radioactive seed for localization of non palpable breast lesions. , 2010, American journal of surgery.
[5] F. Farrokhyar,et al. The relationship between surgical factors and margin status after breast-conservation surgery for early stage breast cancer. , 2009, American journal of surgery.
[6] S. Mclaughlin,et al. A Multi‐site Validation Trial of Radioactive Seed Localization as an Alternative to Wire Localization , 2008, The breast journal.
[7] Kambiz Dowlatshahi,et al. Minimally invasive breast surgery. , 2004, Journal of the American College of Surgeons.
[8] P. Karstaedt,et al. Radioactive seed localization of nonpalpable breast lesions is better than wire localization. , 2004, American journal of surgery.
[9] F. Vicini,et al. Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy. , 2004, International journal of radiation oncology, biology, physics.
[10] A. Wilson,et al. Cosmesis and satisfaction after breast‐conserving surgery correlates with the percentage of breast volume excised , 2003, The British journal of surgery.
[11] A. Rademaker,et al. Factors influencing outcomes for breast conservation therapy of mammographically detected malignancies. , 2003, Journal of the American College of Surgeons.
[12] George Hermann,et al. Mammographic Appearance of Nonpalpable Breast Cancer Reflects Pathologic Characteristics , 2002, Annals of surgery.
[13] Richard Sposto,et al. Palpable Breast Cancers Are Inherently Different From Nonpalpable Breast Cancers , 2001, Annals of Surgical Oncology.
[14] D. Reintgen,et al. Radioguidance for nonpalpable primary lesions and sentinel lymph node(s). , 2001, American journal of surgery.
[15] J. Friedland,et al. Randomized Prospective Evaluation of a Novel Technique for Biopsy or Lumpectomy of Nonpalpable Breast Lesions: Radioactive Seed Versus Wire Localization , 2001, Annals of Surgical Oncology.
[16] D R Chadwick,et al. Wire-directed localization biopsy of the breast: an audit of results and analysis of factors influencing therapeutic value in the treatment of breast cancer. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[17] J. G. Schuler,et al. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. , 1996, Archives of surgery.
[18] M Z Papa,et al. The effect of anesthesia type on needle localization breast biopsy: another point of view. , 1996, American journal of surgery.
[19] K. Gubler,et al. Surgical margins after needle-localization breast biopsy. , 1995, American journal of surgery.
[20] M. Steer,et al. Preoperative localization of nonpalpable breast lesions demonstrated by mammography. , 1976, The New England journal of medicine.
[21] I. V. D. van der Ploeg,et al. 'Radioguided occult lesion localisation' (ROLL) for non-palpable breast lesions: a review of the relevant literature. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[22] A. Luini,et al. Radioguided surgery of occult breast lesions. , 1998, European journal of cancer.
[23] E. Wouters,et al. Chemical pleurodesis with mitoxantrone in the management of malignant effusions. , 1998, European journal of cancer.